Qualitek Labs Valuation
Is 544091 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 544091 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 544091's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 544091's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 544091?
Other financial metrics that can be useful for relative valuation.
What is 544091's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ₹1.14b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 7.3x |
Enterprise Value/EBITDA | 26.3x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 544091's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 28.1x | ||
MITCON MITCON Consultancy & Engineering Services | 36.3x | n/a | ₹1.7b |
CADSYS Cadsys (India) | 21.6x | n/a | ₹3.0b |
512036 Kapil Cotex | 42.1x | n/a | ₹441.0m |
526546 Choksi Laboratories | 12.3x | n/a | ₹418.6m |
544091 Qualitek Labs | 38.5x | n/a | ₹1.1b |
Price-To-Earnings vs Peers: 544091 is expensive based on its Price-To-Earnings Ratio (38.5x) compared to the peer average (28.1x).
Price to Earnings Ratio vs Industry
How does 544091's PE Ratio compare vs other companies in the IN Professional Services Industry?
Price-To-Earnings vs Industry: 544091 is expensive based on its Price-To-Earnings Ratio (38.5x) compared to the Indian Professional Services industry average (25.7x).
Price to Earnings Ratio vs Fair Ratio
What is 544091's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 38.5x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 544091's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.